Mesenchymal Stem Cells


Wuhan University Science & Technology Clinical Study Targeting COVID-19 Severe Pneumonia Uses Mesenchymal Stem Cells

A hospital affiliated with Wuhan University Science and Technology called Puren Hospital is conducting a Phase I/II clinical trial to assess the use of human mesenchymal stem cells in the treatment of COVID-19 Pneumonia. Other Chinese institutions collaborating on...

Regenerative Research in China Targeting COVID-19 Gains Momentum—Evidence of Some Success and an American Venture

Worldwide researchers and clinical investigators develop vaccines, therapeutic treatments and diagnostic tests to take on COVID-19 and in China in addition to these activities some physicians are declaring some initial success utilizing stem cell therapy. Could this...

Pin It on Pinterest